Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Clinical Oncology 2, 119–120 (1 March 2005) | doi:10.1038/ncponc0116
Defining risk in patients with renal-cell carcinoma
Abstract
Mekhail TM et al. (2005) Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. J Clin Oncol 23: 832–841 In 2002, Motzer et al. proposed a prognostic model for survival in patients with previously untreated renal-cell carcinoma, based on patient characteristics and biochemical parameters.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
